FDA Inspection 1082770 — Bella Kaufman
The FDA completed an inspection of Bella Kaufman on Feb 19, 2019 in Ramat Gan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 19, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ramat Gan (Israel)
Additional Details
Clinical Investigator (CI)